ASX Announcements
| 2013 — Quarter 1 |
|---|
| Code | Title | Date | ||
|---|---|---|---|---|
| ACR | Becoming a substantial holder | 20/03/2013 | ||
| ACR | Change in substantial holding | 20/03/2013 | ||
| ACR | Appendix 3B | 04/03/2013 | ||
| ACR | Axiron in Australia | 28/02/2013 | ||
| ACR | Investor presentation, 18 February 2013 | 18/02/2013 | ||
| ACR | Acrux provides half-year update | 18/02/2013 | ||
| ACR | Half Yearly Report and Accounts | 18/02/2013 | ||
| ACR | Ceasing to be a substantial holder | 14/02/2013 | ||
| ACR | Becoming a substantial holder from AMP | 13/02/2013 | ||
| ACR | Allowance of underarm administration patent in United States | 12/02/2013 | ||
| ACR | Change in substantial holding | 08/02/2013 |
| 2013 — Quarter 2 |
|---|
| Code | Title | Date | ||
|---|---|---|---|---|
| ACR | Becoming a substantial holder from WBC | 28/06/2013 | ||
| ACR | Becoming a substantial holder from BTT | 28/06/2013 | ||
| ACR | Axiron launched in Canada | 28/06/2013 | ||
| ACR | Richter to commercialise estradiol spray in ex-US markets | 27/06/2013 | ||
| ACR | Ceasing to be a substantial holder | 06/06/2013 | ||
| ACR | Becoming a substantial holder | 06/06/2013 | ||
| ACR | Change in substantial holding from AMP | 30/05/2013 | ||
| ACR | Lilly and Acrux file lawsuit against Perrigo | 27/05/2013 | ||
| ACR | Acrux announces management changes | 24/05/2013 | ||
| ACR | Becoming a substantial holde rfrom AMP | 15/05/2013 | ||
| ACR | Ceasing to be a substantial holder from AMP | 08/05/2013 | ||
| ACR | Axiron net sales, quarter to 31 March 2013 | 26/04/2013 | ||
| ACR | Change in substantial holding | 22/04/2013 |
| 2013 — Quarter 3 |
|---|
| Code | Title | Date | ||
|---|---|---|---|---|
| ACR | Change in substantial holding | 27/08/2013 | ||
| ACR | Investor Presentation - 27 August 2013 | 27/08/2013 | ||
| ACR | Dividend, June 2013 Results and Company Update | 27/08/2013 | ||
| ACR | Appendix 4E and Financial Report to 30 June 2013 | 27/08/2013 | ||
| ACR | Ceasing to be a substantial holder from NAB | 12/08/2013 | ||
| ACR | Appendix 3B | 08/08/2013 | ||
| ACR | Acrux employee share options | 08/08/2013 | ||
| ACR | Change in substantial holding | 02/08/2013 | ||
| ACR | Becoming a substantial holder- NAB | 31/07/2013 | ||
| ACR | Axiron net sales, quarter to 30 June 2013 | 25/07/2013 | ||
| ACR | Change in substantial holding from AMP | 22/07/2013 |
| 2013 — Quarter 4 |
|---|
| Code | Title | Date | ||
|---|---|---|---|---|
| ACR | Continuation of Pooled Development Fund Program | 20/12/2013 | ||
| ACR | Ceasing to be a substantial holder | 13/12/2013 | ||
| ACR | Change in substantial holding | 12/12/2013 | ||
| ACR | Ceasing to be a substantial holder from NAB | 12/12/2013 | ||
| ACR | Change in substantial holding | 06/12/2013 | ||
| ACR | Change in substantial holding | 04/12/2013 | ||
| ACR | Becoming a substantial holder | 28/11/2013 | ||
| ACR | Axiron Launched in Brazil | 28/11/2013 | ||
| ACR | Becoming a substantial holder from NAB | 27/11/2013 | ||
| ACR | Change of Director's Interest Notice | 27/11/2013 | ||
| ACR | 2013 AGM Results of Meeting | 21/11/2013 | ||
| ACR | 2013 AGM Chairman's Address and Presentation | 21/11/2013 | ||
| ACR | Change in substantial holding | 19/11/2013 | ||
| ACR | Investor Presentation - 14 November 2013 | 14/11/2013 | ||
| ACR | Lilly and Acrux file lawsuit against Actavis | 13/11/2013 | ||
| ACR | Ceasing to be a substantial holder- NAB | 01/11/2013 | ||
| ACR | Change in substantial holding | 31/10/2013 | ||
| ACR | Becoming a substantial holder from NAB | 24/10/2013 | ||
| ACR | Axiron net sales, quarter to 30 September 2013 | 24/10/2013 | ||
| ACR | Becoming a substantial holder | 22/10/2013 |